Search research articles
Contact Us
Filters
Showing results (11-20 of 304) with videos related to
Page
of 31
Sort By:
Pediatric Nephrology (Berlin, Germany)
|
May 20, 2014
Ezetimibe treatment should be considered for patients with sitosterolemia
Miao Hu, Brian Tomlinson
Expert Opinion on Drug Metabolism & Toxicology
|
April 10, 2024
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
Brian Tomlinson, Paul Chan
Expert Opinion on Drug Metabolism & Toxicology
|
August 19, 2010
Pharmacokinetic evaluation of lanreotide
Miao Hu, Brian Tomlinson
Annals of Translational Medicine
|
August 5, 2021
Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension
Weiwei Zeng, Brian Tomlinson
Expert Opinion on Pharmacotherapy
|
January 10, 2025
Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Brian Tomlinson, Paul Chan
Current Opinion in Investigational Drugs (London, England : 2000)
|
October 2, 2007
Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes
Ying Wang, Brian Tomlinson
Bosnian Journal of Basic Medical Sciences
|
October 30, 2021
Effect of bisoprolol on central aortic systolic pressure in Chinese hypertensive patients after the initial dose and long-term treatment
Weiwei Zeng, Brian Tomlinson
The New England Journal of Medicine
|
November 13, 2014
Niacin for reduction of cardiovascular risk
Miao Hu, Brian Tomlinson
Cardiovascular Drugs and Therapy
|
September 19, 2025
Statin-Related Transaminitis-Is It Necessary to Stop Statins?
Brian Tomlinson, Weiwei Zeng
Annals of Translational Medicine
|
September 17, 2021
Causes and outcome of rhabdomyolysis in patients admitted to medical wards in the Prince of Wales Hospital
Weiwei Zeng, Brian Tomlinson
Page
of 31
Search research articles
Search
Showing results (11-20 of 304) with videos related to
Sort By:
Page
of 31
Pediatric Nephrology (Berlin, Germany)
|
May 20, 2014
Ezetimibe treatment should be considered for patients with sitosterolemia
Miao Hu, Brian Tomlinson
Expert Opinion on Drug Metabolism & Toxicology
|
April 10, 2024
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
Brian Tomlinson, Paul Chan
Expert Opinion on Drug Metabolism & Toxicology
|
August 19, 2010
Pharmacokinetic evaluation of lanreotide
Miao Hu, Brian Tomlinson
Annals of Translational Medicine
|
August 5, 2021
Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension
Weiwei Zeng, Brian Tomlinson
Expert Opinion on Pharmacotherapy
|
January 10, 2025
Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Brian Tomlinson, Paul Chan
Current Opinion in Investigational Drugs (London, England : 2000)
|
October 2, 2007
Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes
Ying Wang, Brian Tomlinson
Bosnian Journal of Basic Medical Sciences
|
October 30, 2021
Effect of bisoprolol on central aortic systolic pressure in Chinese hypertensive patients after the initial dose and long-term treatment
Weiwei Zeng, Brian Tomlinson
The New England Journal of Medicine
|
November 13, 2014
Niacin for reduction of cardiovascular risk
Miao Hu, Brian Tomlinson
Cardiovascular Drugs and Therapy
|
September 19, 2025
Statin-Related Transaminitis-Is It Necessary to Stop Statins?
Brian Tomlinson, Weiwei Zeng
Annals of Translational Medicine
|
September 17, 2021
Causes and outcome of rhabdomyolysis in patients admitted to medical wards in the Prince of Wales Hospital
Weiwei Zeng, Brian Tomlinson
Page
of 31